Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sitong Guo

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|February 7, 2025
Hepatic epithelioid hemangioendothelioma with <i>TFE3</i> rearrangement: a case report and literature reviewKe Meng, Xingrong Yang, Sitong Guo, et al.
Medicine|February 17, 2025
Invasive inflammatory fibroid polyp of the stomach: A case report and literature reviewXingrong Yang, Sitong Guo, Ke Meng, et al.
Technology in Cancer Research & Treatment|December 29, 2020
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell CarcinomaZhibin Jing, Sitong Guo, Peng Zhang, et al.
Head & Neck|November 3, 2021
FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cellsZhibin Jing, Sitong Guo, Yao Li, et al.
Asian Journal of Surgery|September 12, 2024
Prostatic Malakoplakia: A case reportSitong Guo, Yuejun Liu, Wenbo Wang, et al.
Asian Journal of Surgery|November 19, 2023
A case of benign Brenner tumor of the ovary with tubal-tunica parietal mesonephric cystLi Kong, Sitong Guo, Ke Meng, et al.
Asian Journal of Surgery|November 28, 2024
Langerhans cell sarcoma in the skull: A very rare case reportXingrong Yang, Sitong Guo, Qiushi Xu, et al.
Biomimetics (Basel, Switzerland)|September 27, 2023
LFVB-BioSLAM: A Bionic SLAM System with a Light-Weight LiDAR Front End and a Bio-Inspired Visual Back EndRuilan Gao, Zeyu Wan, Sitong Guo, et al.
Eye (London, England)|October 2, 2024
Unique properties of clinical manifestation and magnetic resonance imaging for differential diagnosis of optic nerve hemangioblastomaHongjuan Liu, Bentao Yang, Yue Chen, et al.
Frontiers in Oncology|October 13, 2022
Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysisYan Li, Xueyan Liang, Tong Yang, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|February 7, 2025
Hepatic epithelioid hemangioendothelioma with <i>TFE3</i> rearrangement: a case report and literature reviewKe Meng, Xingrong Yang, Sitong Guo, et al.
Medicine|February 17, 2025
Invasive inflammatory fibroid polyp of the stomach: A case report and literature reviewXingrong Yang, Sitong Guo, Ke Meng, et al.
Technology in Cancer Research & Treatment|December 29, 2020
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell CarcinomaZhibin Jing, Sitong Guo, Peng Zhang, et al.
Head & Neck|November 3, 2021
FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cellsZhibin Jing, Sitong Guo, Yao Li, et al.
Asian Journal of Surgery|September 12, 2024
Prostatic Malakoplakia: A case reportSitong Guo, Yuejun Liu, Wenbo Wang, et al.
Asian Journal of Surgery|November 19, 2023
A case of benign Brenner tumor of the ovary with tubal-tunica parietal mesonephric cystLi Kong, Sitong Guo, Ke Meng, et al.
Asian Journal of Surgery|November 28, 2024
Langerhans cell sarcoma in the skull: A very rare case reportXingrong Yang, Sitong Guo, Qiushi Xu, et al.
Biomimetics (Basel, Switzerland)|September 27, 2023
LFVB-BioSLAM: A Bionic SLAM System with a Light-Weight LiDAR Front End and a Bio-Inspired Visual Back EndRuilan Gao, Zeyu Wan, Sitong Guo, et al.
Eye (London, England)|October 2, 2024
Unique properties of clinical manifestation and magnetic resonance imaging for differential diagnosis of optic nerve hemangioblastomaHongjuan Liu, Bentao Yang, Yue Chen, et al.
Frontiers in Oncology|October 13, 2022
Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysisYan Li, Xueyan Liang, Tong Yang, et al.
Pageof 5